EUVIMEDOpdag EUVIMED
KohortenstudieOpen access

Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study

Xiaoling Wang iD, Rui Rao iD, Hua Li iD, Xiaoping Lei iD, Wenbin Dong iD

JMIR Pediatrics and Parenting · 2024-09-18 · 7 · e60330-e60330

DOI: 10.2196/60330 ↗

At a glance

Kohortenstudie in JMIR Pediatrics and Parenting, published online on 2024-09-18. Written by Xiaoling Wang and 4 co-authors. Institution: Jinan University, Guangzhou, China. Cited 11 times so far (Crossref); 44 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Retinopathy of prematurity (ROP) is a leading cause of visual impairment and blindness in preterm infants.

Objective

This study sought to investigate the association between red blood cell (RBC) transfusion and ROP in very preterm infants (VPIs) to inform clinical strategies for ROP prevention and treatment.

Methods

We designed a prospective multicenter cohort study that included VPIs and follow-up data from January 2017 to December 2022 at 3 neonatal clinical medicine centers. They were categorized into a transfusion group (infants who received an RBC transfusion within 4 wk) and a nontransfusion group. The relationship between RBC transfusion and ROP incidence was assessed using binary logistic regression, with subgroup analyses based on gestational age, birth weight, sex, and sepsis status. Inverse probability of treatment weighting and propensity score matching were applied to account for all potential confounding factors that could affect ROP development, followed by sensitivity analysis.

Results

The study included 832 VPIs, including 327 in the nontransfusion group and 505 in the transfusion group. The transfusion group had a lower average birth weight and gestational age and a greater incidence of ROP, ≥stage 2 ROP, and severe ROP. Logistic regression analysis revealed that the transfusion group had a significantly greater risk of ROP (adjusted odds ratio [aOR] 1.70, 95% CI 1.14‐2.53, P =.009) and ≥stage 2 ROP (aOR 1.68, 95% CI 1.02‐2.78, P =.04) but not severe ROP (aOR 1.75, 95% CI 0.61‐5.02, P =.30). The trend analysis also revealed an increased risk of ROP with an increasing number of transfusions and a larger volume of blood transfused ( P for trend

Subjects

Author keywords

RBCROPVPIblindnessred blood cellred blood cell transfusionretinopathy of prematurityvery preterm infantsvisual impairment

Authors and institutions

  • Jinan University, Guangzhou, China.
  • Department of Neonatology, Children's Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

ORCID profiles: Xiaoling Wang, Rui Rao, Hua Li, Xiaoping Lei, Wenbin Dong

Cite

APA

Wang, X., Rao, R., Li, H., Lei, X., & Dong, W. (2024). Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study. JMIR Pediatrics and Parenting, 7, e60330-e60330. https://doi.org/10.2196/60330

Vancouver

Wang X, Rao R, Li H, Lei X, Dong W. Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study. JMIR Pediatrics and Parenting. 2024;7:e60330-e60330. doi:10.2196/60330

BibTeX
@article{Wang2024,
  author = {Wang, Xiaoling and Rao, Rui and Li, Hua and Lei, Xiaoping and Dong, Wenbin},
  title = {Red Blood Cell Transfusion for Incidence of Retinopathy of Prematurity: Prospective Multicenter Cohort Study},
  journal = {JMIR Pediatrics and Parenting},
  year = {2024},
  volume = {7},
  pages = {e60330--e60330},
  doi = {10.2196/60330}
}
Start for free →